Effects of voltage-gated K+ channel blockers in gefitinib-resistant H460 non-small cell lung cancer cells. [electronic resource]
Producer: 20130502Description: 5279-84 p. digitalISSN:- 1791-7530
- Adenocarcinoma -- drug therapy
- Adenocarcinoma of Lung
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Cycle -- drug effects
- Cell Growth Processes -- drug effects
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Drug Synergism
- Gefitinib
- Humans
- Kv1.1 Potassium Channel -- antagonists & inhibitors
- Lung Neoplasms -- drug therapy
- Male
- Mice
- Mice, Nude
- Peptides -- administration & dosage
- Quinazolines -- administration & dosage
- RNA, Messenger -- biosynthesis
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.